CEO & Founder at Machavert Pharmaceuticals - , Colorado, United States
CEO & Founder
Contact Jakub Staszak-Jirkovsky
Executive Assistant
Contact Beata Staszak-Jirkovska
Senior Analytical Chemist
Contact Chris Johnson
Memeber of the Board of Directors
Contact Michal Drozd
Machavert develops first in class small molecule RAL GTPase inhibitors that target KRAS mutant cancers growth and metastasis.